title: Fibrosing cholestatic hepatitis after methotrexate and prednisone therapy for rheumatoid arthritis.
abstract: OBJECTIVE
  Fibrosing cholestatic hepatitis is an aggressive and usually fatal form of viral hepatitis in immunosuppressed patients. We assessed the hepatotoxicity of methotrexate and prednisolone combination therapy in the background of hepatitis B virus infection.
  
  
  METHODS
  We report the clinical course of a 55-year-old woman who underwent a deceased-donor liver transplant for fulminant liver failure.
  
  
  RESULTS
  The patient's medical history was significant for hepatitis B virus infection and rheumatoid arthritis. Methotrexate and prednisolone combination therapy were started 5 months earlier. The patient was hospitalized because of an elevation in her liver enzymes and total bilirubin. Deterioration of liver functions and encephalopathy were developed 5 weeks after hospital admission. A deceased-donor liver transplant was performed, and pathological examination of recipient liver revealed fibrosing cholestatic hepatitis. The patient was reoperated on for bile leak and discharged 40 days after the deceased-donor liver transplant.
  
  
  CONCLUSIONS
  The natural course of the current case was similar to previously reported cases with fibrosing cholestatic hepatitis. Clinicians should consider the potential hepatotoxicity of methotrexate and steroid therapy in hepatitis B virus infected patients.
authors.affiliation: Department of Surgery, Karadeniz Technical University, School of Medicine, Farabi Hospital, Trabzon, Turkey.
authors.forename: Serdar
authors.initials: S
authors.lastname: Topaloğlu
authors.forename: Adnan
authors.initials: A
authors.lastname: Çalık
authors.forename: Orhan
authors.initials: O
authors.lastname: Kalaycı
authors.forename: Emine
authors.initials: E
authors.lastname: Çeşmecioğlu
authors.forename: Ümit
authors.initials: Ü
authors.lastname: Çobanoğlu
authors.forename: Yusuf
authors.initials: Y
authors.lastname: Uzun
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy*; D001706:Biopsy; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis / Q000209:etiology* / Q000601:surgery; D002780:Cholestasis, Intrahepatic / Q000139:chemically induced* / Q000175:diagnosis / Q000601:surgery; D004359:Drug Therapy, Combination; D005260:Female; D006509:Hepatitis B / Q000150:complications* / Q000175:diagnosis; D006801:Humans; D008103:Liver Cirrhosis / Q000139:chemically induced* / Q000175:diagnosis / Q000601:surgery; D017114:Liver Failure, Acute / Q000175:diagnosis / Q000209:etiology / Q000601:surgery; D016031:Liver Transplantation; D008727:Methotrexate / Q000009:adverse effects*; D008875:Middle Aged; D011241:Prednisone / Q000009:adverse effects*; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D011241:Prednisone; D008727:Methotrexate